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Variousenzymeidentiﬁcationprotocols involvinghomologytransferby sequence-sequence orproﬁle-sequence comparisonshave
been devised which utilise Swiss-Prot sequences associated with EC numbers as the training set. A proﬁle HMM constructed
for a particular EC number might select sequences which perform a diﬀerent enzymatic function due to the presence of certain
fold-speciﬁc residues which are conserved in enzymes sharing a common fold. We describe a protocol, ModEnzA (HMM-ModE
Enzyme Annotation), which generates proﬁle HMMs highly speciﬁc at a functional level as deﬁned by the EC numbers by
incorporating information from negative training sequences. We enrich the training dataset by mining sequences from the NCBI
Non-Redundant database for increased sensitivity. We compare our method with other enzyme identiﬁcation methods, both
for assigning EC numbers to a genome as well as identifying protein sequences associated with an enzymatic activity. We report
asensitivityof88%andspeciﬁcityof95%inidentifyingECnumbers andannotatingenzymaticsequences fromtheE. coligenome
whichishigherthananyothermethod.Withthenext-generation sequencing methodsproducing ahugeamountofsequencedata,
the development and use of fully automated yet accurate protocols such as ModEnzA is warranted for rapid annotation of newly
sequenced genomes and metagenomic sequences.
1.Introduction
Emergence of next-generation sequencing technologies [1]
and complete genome sequencing projects have greatly facil-
itated the process of unraveling the full repertoire of biolog-
ical functions that an organism possesses. For a pathogenic
organism, such a compilation of functions has a direct
implication in identifying potential drug targets, for exam-
ple, selecting genes or functions which are unique to the
pathogen and not present in the host organism. Metabolic
enzymes have for long been considered as a promising group
from which such drug targets can be identiﬁed [2]. Enzymes
form a sizable part of the druggable genome. Druggability
is equated with the presence of certain folds in the proteins
which can favour interactions with drug-like chemical
compounds. The active sites or ligand binding pockets of
e n z y m e sa r ep r i m ee x a m p l e so fd r u g g a b l ef o l d ss u c ht h a t
around 47% of the small molecule drugs available in the
market have an enzyme target [3, 4]. Enzyme drug targets
havebeenidentiﬁedandexploitedinanumberofpathogenic
protozoans [5–7], bacteria such as M. tuberculosis [8, 9], and
fungal pathogens such as C. albicans [10–12]. Metagenome
projects resulting from recent advances in environmental
shotgunsequencingalso provideopportunitiesformetabolic
enzyme mapping as well as studying the environmental
impact on evolutionof metabolism [13, 14].2 Advances in Bioinformatics
Metabolic reconstruction is a process that aims to
develop a complete overview of the metabolic capabilities
of an organism from the genome or metagenome sequence.
There are various databases to aid metabolic reconstruction
which integrate and curate data from diﬀerent sources, for
example KEGG [15] which combines genomic, chemical,
and network information, PUMA2 [16]w h i c hp r o v i d e s
an array of tools for comparative genomics, and MetaCyc
[17] which is a multiorganism pathway/genome database.
Accurate identiﬁcation of metabolic enzymes from a fully
sequenced genome is a very important step towards such
a reconstruction. The most common approach for detection
of an enzyme function in a given genome is on the basis
of sequence similarity with homologues whose function is
known,which canbeaccomplishedbyusingeithersequence-
sequence comparison methods such as BLAST [18]a n d
FASTA [19] or proﬁle-sequence comparison methods like
PSI-BLAST[20] and HMMER [21]. Diﬀerent protocolshave
been developed using these methods that detect enzymatic
function at the level of the EC number. PRIAM [22],
for example, generates position-speciﬁc scoring matrices
for collections of sequences which are associated with the
same EC number which are then used to score sequences
in a genome using reverse positionspeciﬁc blast (RPS-
BLAST) [23]. MetaSHARK [24] improves on the sensitivity
of PRIAM enzyme prediction by using hidden Markov
models to identify corresponding enzymes directly from the
genomic sequence.Other approaches for enzymatic function
inference include checking for the presence of a conserved
pattern or motif and identiﬁcation of functionally critical
residues. EFICAz [25] is a protocol which combines these
two approaches along with an iterative HMMER-based
procedureforgeneratingmultiplealignmentsforECnumber
families and pairwise sequence comparison using a family-
speciﬁc identity threshold. It has recently been extended by
including additional components based on support vector
machine (SVM) models [26].
Metabolic enzymes belonging to certain core pathways
are conserved in all three domains of life (namely archaea,
bacteria, and eukaryotes) and can thus be easily identiﬁed
using sequence homology [27]. However, there are a total
of 4905 unique EC number entries in the enzyme [28]
database release of 19 January, 2010, out of which only
2507 entries have one or more sequence associated with
them. This has led to developmentof various algorithms and
methods which try to associate sequences with enzymatic
activities hitherto unannotated in an organism (hence,
a pathway “hole” [29]) and can be collectively termed as
“hole-ﬁlling” algorithms. A variety of other information is
used in addition to the sequences, for example topology of
the metabolic network [30, 31] or genomic evidences such
as chromosomal clustering of operons [32], a combination
of both [29], or an ensemble of various kinds of methods
such as gene coexpression, phylogenetic proﬁle cooccurence,
proteinfusion, and so forth [33, 34]. Whereas these methods
can be used in conjunction or as a complement to the
proﬁle-sequence comparison methods to obtain a complete
overviewofthemetabolicreactionsofanorganism, thelatter
group of methods, nevertheless, still retains its importance.
A proﬁle HMM constructed using Swissprot sequences
for a particular EC number might score sequences belonging
to other EC groups very highly if the enzymatic activities
have developed in the same protein fold and therefore
share certain fold-speciﬁc residues [35]. For example, the
Alpha/Beta hydrolase fold (SCOP [36] classiﬁcation) has
35 protein families which span through various enzymatic
functions in terms of EC numbers. A group of 9 EC
numbers, all of which are carboxylic ester hydrolases (EC
3.1.1) with diﬀerent substrate speciﬁcities, are included in
this fold group (Supplementary Table ST1 available online
at doi:10.1155/2011/743782) and would be expected to
have common fold-speciﬁc signals which would be con-
served in sequences belonging to these EC numbers. As
a result, the proﬁle HMM for the EC 3.1.1.8 used with
default parameters selects sequences from 5 other EC
groups (Supplementry Figure SF1, inset available online at
doi:10.1155/2011/743782). Figure SF1 also depicts the over-
all structural similarity between representatives from each of
the six EC groups.
We have earlier described the use of negative training
sequences(i.e.,sequencesofdiﬀerentfunctions related tothe
training sequences by virtue of sharing a common fold) to
both optimise the discrimination threshold as well as modify
theemission probabilitiesoftheproﬁleHMMs toincrease its
s p e c i ﬁ c i t y .W eh a v eu s e dr e l a t i v ee n t r o p yo ft h ea m i n oa c i d
probabilities of the positive and negative training sequences
to select residues in the positive alignment which are respon-
sibleforitsspeciﬁcfunction asopposedtoresidueswhich are
similarly conservedinboththenegative andpositive training
sequence sets [35]. In this paper, we describe ModEnzA
(HMM-ModE Enzyme Annotation), where we apply HMM-
ModE to create proﬁle HMMs which are speciﬁc at the
functional levelas deﬁned bythe ECclassiﬁcation. We enrich
the training set by mining sequences from the nonredundant
(NR) database for increased coverage of the EC numbers
and thus, increased sensitivity. We use the Markov clustering
algorithm (MCL) [37] to partition the EC sequence sets
into clusters corresponding to nonorthologous sequences
or oligomeric subunits. The ModEnzA protocol is used
to annotate metabolic enzymes from completely sequenced
reference genomes. We present a comparative analysis of our
protocol with other methods used for genome-wide enzyme
identiﬁcation such as PRIAM, MetaShark, and EFICAz.
2.Methods
2.1. Collection of Training Sequences
2.1.1. Training Sequences from Enzyme/Swiss-Prot. The
expasy enzyme database (release of 19 Jan 2010) had a total
of 4905 unique EC number entries out of which 2507 were
associated with a total of 180315 sequences. These 2507
entries were divided into 2 groups, those having 3 or more
sequences and those having just 1 or 2 sequences. The 1910
EC numbers which had 3 or more sequences in Swiss-Prot
weredesignatedasTierI(Figure 1)whilethesequencesinthe
latter group were used as queries to mine similar sequencesAdvances in Bioinformatics 3
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Figure 1: Flow diagram of the ModEnzA protocol.
from the nonredundant protein database (NR) database as
follows.
2.1.2. Mining of the Nonredundant Protein Database. There
were 597 EC numbers that had just 1 or 2 sequences asso-
ciated with them in the Swiss-Prot database. These were
used as BLASTp queries to mine similar sequences from the
NR database at NCBI (http://www.ncbi.nlm.nih.gov/sites/
entrez?db=Protein). We used an E-value cut-oﬀ of 10−35,
a percent identity range of 50 < × < 99 and a query coverage
of 80% as the primary ﬁlters. If a sequence appeared as
BLAST hit in more than one EC numbers, it was removed
from all the EC number ﬁles. We removed sequences with
ambiguous annotations such as “hypothetical”, “unnamed”,
“unknown”, “unclassiﬁed”, and “unidentiﬁed”. While we
did not follow a systematic testing approach to ﬁx these
parameters, we nevertheless tried various combinations of
the parameters (e-values of 10−30 and 10−35, percent identity
ranges 50–99, 75–99, 75–95, etc). The ﬁnal set of parameters
was decided upon after visual inspection of the annotations
of the gathered sequences looking for the least amount
sequences with ambiguous sequence descriptions and the
most number of EC groups with more than 3 sequences.
After the ﬁltering step, we were left with 450 EC number
groupswith 3ormoresequences.To thesewe furtherapplied
a reciprocal BLAST best hit criterion, wherein we discarded
those NR sequences which did not have the original query
swissprot sequence as their top hit. We obtained 364 EC
groups having 3 or more sequences which ﬁt this criterion.
These were designated as Tier II proﬁles (Figure 1). The
remaining 86 EC groups which also had 3 or more sequences
but did not have suﬃcient reciprocal best hits were desig-
nated as Tier III (Figure 1).
2.2. Clustering Sequences Using the Markov Clustering Algo-
rithm (MCL) [37]. The sequences belonging to each EC
number in Tier I were clustered into subgroups with MCL
using pairwise BLAST scores as input. This resulted in
2313 distinct subgroups having 3 or more sequences. These
were considered as separate proﬁles called as Tier I proﬁles,
for example the 7 subgroups of EC number 3.1.1.4 were
designated as 3.1.1.4 1 through 3.1.1.4 7a n dc o n v e r t e d
into separate HMMs. There were 117 EC numbers which
had subgroups containing just 1 or 2 sequences. These
subgroupswere discarded aftermanual inspection. Similarly,
the sequences in the other tiers were also clustered using
MCL. We obtained 370 subgroups with more than three
sequences in Tier II and 86 subgroups in Tier III making
a total of 2769 distinct ModEnzA proﬁles.4 Advances in Bioinformatics
2.3. HMM-ModE Proﬁles. The subgroups for each EC num-
ber were used to construct HMM proﬁles and HMM-
ModE proﬁles as previously described [35]. Brieﬂy, HMMs
are generated for each subgroup using hmmbuild from the
HMMER package [21] after aligning the sequences using
MUSCLE[38]. The discrimination threshold is optimised by
performing an n-fold cross-validation routine, partitioning
the training sequences into n train and test sets such that
each sequence is part of at least one test set. For each test
set t, a proﬁle HMM created from the remaining (n − 1)
sets is used to score the sequences to get a True Positive
(TP) score distribution. False positives (FP) are identiﬁed
from the Swiss-Prot sequences (i.e those sequences that
perform an enzymatic function which is diﬀerent from that
of the EC number for which the HMM was generated) using
hmmsearch from HMMER. The FPs are also partitioned into
n sets such that each FP sequence is part of at least one
set. The proﬁle HMM created for each (n − 1) subset is
also used to score the corresponding FP set to get an FP
score distribution. The sensitivity, speciﬁcity, and Matthews
correlation coeﬃcient (MCC) [39] distributions for each of
n sets is calculated using these TP and FP score distributions.
The optimal discrimination threshold is identiﬁed as the
mid-point of the MCC distribution averaged over the n sets.
The number of cross-validation sets n is deﬁned as
follows:
n = 10, ∀ subgroups with sequences ≥ 10,
n =
⎧
⎨
⎩
Number of FP if FP <TP
Number of TP if FP >TP
⎫
⎬
⎭
∀ subgroups with sequences < 10.
(1)
If more than3 false positivesare identiﬁed,thenthese are
again aligned and converted into HMMs and used to modify
t h et r u ep o s i t i v ep r o ﬁ l eH M Ma sd e s c r i b e de a r l i e r[ 35]. In
caseofalarge numberoffalse positivesfrom thepreclassiﬁed
training set, to avoid issues of multiple alignments of very
large datasets, we restrict the number of false positives to
200. The false positives are ﬁrst clustered using MCL, and
then sequences are randomly selected from the clusters
proportionate to the size of the clusters such that the ﬁnal
number is 200. An optimized threshold is then calculated as
above. In case no false positives are selected by the original
HMM, it is used with default parameters.
All methods described above were automated using
scripts written in-house, to form the workﬂow described in
Figure 1, and are available from the authors upon request.
2.4. Benchmark Datasets and Enzyme Identiﬁcation Programs.
For the bacterial genomes (E. coli, B. aphidicola,a n dM.
pneumoniae)we usedthecorrespondingHAMAP[40]anno-
tations as the benchmark for comparing the various en-
zyme identiﬁcation methods. The genome sequences for
these and the corresponding annotations were downloaded
from http://expasy.org/sprot/hamap/bacteria.html.W eu s e d
hmmsearchtoscoretheproteinsequencesforagivengenome
with the ModEnzA proﬁles generated above.
T h es e q u e n c eI D si d e n t i ﬁ e db ye a c ho ft h em e t h o d s
which had a 4-digit EC number annotation in HAMAP were
considered as true positives (TP). False negatives (FN) were
those predicted sequence IDs which had EC annotations in
HAMAP but were not selected by a method whereas false
positives (FP) were predicted sequences which actually did
nothaveanECnumber annotation inHAMAP.Similarly,for
assigning EC numbers, true positives were those predicted
EC numbers which had corresponding sequences in the
HAMAP genome annotations, false positives, those that
d i dn o ta n df a l s en e g a t i v e sw e r eE Cn u m b e r sw h i c hw e r e
present in HAMAP but not predicted by a method. For the
P. falciparum genome, we used EC annotations in PlasmoDB
as the benchmark. The sequence annotation and EC number
information for P. falciparum can be obtained from http://
plasmodb.org/plasmo/. True positives, false positives, and
false negatives were deﬁned as earlier. For the ROC curves
for P. falciparum we used the KEGG annotations as the
benchmark.
ThePRIAMprogram[22]andthecorrespondingproﬁles
were downloaded from http://priam.prabi.fr/REL JUL06/
index jul06.html and used with an RPS-BLAST e-value
cutoﬀ of 10−30on the protein sequences of the genomes.
The MetaShark package [24] was obtained from http://
bmbpcu36.leeds.ac.uk/shark/ This was run using an e-value
cutoﬀ of 10−30 on the genomic DNAsequences of the organ-
isms (including plasmids in case of B. aphidicola)o b t a i n e d
from NCBI ftp://ftp.ncbi.nih.gov/ The EFICAz enzyme an-
notations [25] for various organisms were obtained from
http://cssb2.biology.gatech.edu/EFICAz/.
The percentage sensitivity and speciﬁcity of each method
was calculated as
sensitivity =
 
TP
(TP + FN)
 
∗ 100,
speciﬁcity =
 
TP
(TP + FP)
 
∗ 100.
(2)
2.5.Receiver-Operator Characteristic Curves. Forcomparison
of ModEnzA with PRIAM and MetaShark the ModEnzA
proﬁles for all EC numbers were rebuilt using the July
2006 version of ENZYME database which is used by the
current versions of both PRIAM and MetaShark. The ROC
curves (1-speciﬁcity versus sensitivity) were plotted for each
of the three methods (PRIAM, MetaShark, and ModEnzA)
on the four genomes by comparing against the benchmark
sets mentioned above. The three programs were run on
the genomes using an E-value threshold (RPS-BLAST, PSI-
BLAST, and hmmsearch E-values for PRIAM, MetaShark,
and ModEnzA, resp.) of 10. For PRIAM and MetaShark,
the resulting E-values were binned and a threshold sweep
was used to calculate the sensitivity and speciﬁcity at each
E-value threshold. For ModEnzA, similar calculations were
performed using a sweep through the hmmsearch scores
(Figure 2(a)). The MetaShark output consists only of EC
numbers, hence its sensitivity and speciﬁcity values were
calculated only on the basis of EC number comparisons,
whereas for PRIAM and ModEnzA, both the correct ECAdvances in Bioinformatics 5
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Figure 2: ROC curves for genome-wide enzyme identiﬁcation using the ModEnzA proﬁles. The classiﬁcation of the complete genomes of
the four organisms is shown in (a). A fraction of the EC number proﬁles (284 out of 2075 Tier I ModEnzA proﬁles) were retrained with an
older version of the ENZYME database and compared to PRIAM and MetaShark (b). ModEnzA-RT-Retrained ModEnzA proﬁles.6 Advances in Bioinformatics
numbers predicted as well as the correct sequences assigned
were used.
3.Resultsand Discussion
3.1. Enriching the Training Dataset. One of the crippling
issuesin biologicaldata modeling isthe incompletenature of
the training data. We have used both Swiss-Prot [41]a n dN R
sequences for generating proﬁles speciﬁc for EC numbers.
There were 1910 EC numbers which had 3 or more Swiss-
Prot sequences associated with them. These form our Tier I
proﬁles, which can be used to annotate sequenceswith a very
high degree of conﬁdence, since they were generated from
curated training sequences. We considered three sequences
as the minimum number required to generate a multiple
alignment and consequently for constructing HMMs. Even
though these proﬁles with 3 sequences (and in general all
proﬁles with very few training sequences) are not expected
to be representative of the protein function, they are, never-
theless, included in the ModEnzA protocol as place holders
which would become more accurate as they are populated
with more sequences in future.
The training set for EC numbers which had less than
3 Swiss-Prot sequences was enriched by mining sequences
from the NR database using BLASTp with parameters suit-
ably modiﬁed for increased sensitivity (namely, BLOSUM62
substitution matrix and a lower than default value for “f”,
the hit extension parameter). The hits were screened with
as t r i n g e n tE-value cut-oﬀ of 10−35. Hits having more than
99% identity or those having less than 50% identity with the
query sequence were left out to remove identical sequences
and potential false positives while ensuring variability in the
protein family. This resulted in 450 EC groups (which had
more than three sequences) out of which in 364 EC groups
(Tier II), all the mined sequences picked up the original
swissprot query sequence as the reciprocal best BLAST hit.
The remaining 86 were put in a separate group designated
as Tier III. By enriching the training data set, we have
populated an additional 450 enzyme functions with high-
quality sequences, providing increasing coverage over the
set of enzyme functions. This is still not comprehensive—
the coverage that our proﬁles provide, including Tier II
and III, is still only 48% of the total number of enzyme
functions known. However, the same method developed for
known functions may be applied to new functions as they
are mapped with sequences in future versions, of which
this enrichment exercise serves as an example. The coverage
within an organism is expected to be much higher, as most
common functions are mapped with known sequences.
3.2. Clustering Training Sequences with Markov Clustering
Algorithm (MCL). Sequences belonging to the same EC
group and thus performing the same enzymatic function,
might have complex relationships amongst them in terms of
sequence similarity due to the presence of (1) heteromeric
multiple subunits of the enzymes, (2) nonorthologous or
unrelated sequences performing the same function, or (3)
sequences that can perform more than one enzymatic func-
tion [22]. Clustering the sequences for a particular EC
number based on a similarity score is therefore an important
requirement to separate these multiple subunits or non-
orthologous sequences.
We used MCL to cluster the sequences of an EC
group into subgroups after removing sequences which had
“fragment” as part of the annotation. To validate our use
of automated clustering, we compared our MCL clusters for
some of the cases mentioned above with available structural
information from PDB [42]. For example, MCL clusters the
swissprot sequences for the DNA-directed RNA polymerase
(EC 2.7.7.6) into 14 subgroups (PRIAM has 51 separate
proﬁles for EC 2.7.7.6). We tested the ModEnzA proﬁles for
EC 2.7.7.6 on a set of sequences of the structural subunits
for the RNA polmerase downloaded from PDB. The yeast
polymerase (PDB ID: 3H0G) has 12 subunits while the
prokaryotic polymerase from E. coli (PDB ID: 3LU0) has
5 subunits (excluding the sigma subunit). In each case, the
sequences corresponding to diﬀerent subunits were picked
upbyadiﬀerentModEnzAsubgroupproﬁle(Supplementary
Table ST2 available online at doi:10.1155/2011/743782). We
also manually inspected the “singlet” sequences, that is
the sequences which the MCL clustering procedure cannot
assign to any cluster bigger than size 3 and thus have to
be discarded while making the proﬁles. We obtained 2313
distinct MCL subgroups with more than 3 sequences in Tier
I. There were 117 EC numbers (with a total of 215 “singlet”
sequences) with subgroups having less than 3 sequences.
These were subjected to a BLASTp analysis against the
NR database and the results were manually inspected to
ascertainthefunctionalneighbours(topBLASThits)ofthese
sequences. Out of the 215 sequences that were so tested,
23% (55) matched with sequences which had a diﬀerent
functional annotation than the original EC group suggesting
that these might have had possible errors in annotation.
Some of the sequences (14 or 6%) were shorter than most
of the other sequences in that EC group (probably fragments
or truncated proteins) whereas a fraction (3%) were longer
than the rest. Another 15 sequences (6%) were not clustered
because they belonged to a diﬀerent sub-unit of the enzyme,
indicating the ability of MCL to clearly distinguish between
heteromeric subunits of enzymes. Whereas 23% sequences
did not show any signiﬁcant hits in the BLAST search,
a sizable fraction (30%) were such that they had the correct
annotation but not a suﬃcient number of neighbours to
formaseparatecluster.These werenotincludedintheproﬁle
construction; however, they couldbe used formining similar
sequences from the NR database if they match sequences
withthesamefunctionastheECgroup.Asmentionedabove,
all of the 215 sequences were not included in the proﬁle
generation step. This exercise demonstrates the eﬃcacy
of using an MCL-based clustering approach in separating
enzyme subgroups.
The PRIAM method identiﬁes the longest homologous
subsequences shared within the set of sequences associated
with EC number (EC group) as a single module or domain.
It initially takes the shortest sequence in the group as
a module and then proceeds to identify similar subse-
quences within a given EC group using PSI-BLAST. The
matching subsequencesare removedfrom thecorrespondingAdvances in Bioinformatics 7
sequences and the shortest sequence identiﬁed to start the
next iteration [22]. Complete linkage clustering using a
30% sequence identity cutoﬀ has also been employed to
create subgroups as in the EFICAz protocol [25, 26].
The most populated and most divergent subgroup is then
converted into a proﬁle HMM which is used to add
sequences with E-value < 0.01 which have at least one
conserved potential active site residue. These subgroups are
termed as CHIEFc (conservation-controlled HMM iterative
procedure for enzyme family classiﬁcation) families [25].
The Markov clustering algorithm (MCL) provides for an
accurate, unsupervised, and fully automated protocol for
clustering the sequences of a given EC number. MCL avoids
potential problems associated with module architecture-
based clustering as well as the pairwise protocols of dealing
with similarity relationships which have been used earlier
[43]. It also circumvents the requirement of using arbitrary
sequence identity cutoﬀs as described above or manual
assignment. Instead, the graph-theoretic representation of
the similarity scores allows for the detection of global
patterns of sequence similarity in a single step [37].
3.3. Validation and Comparison of ModEnzA with Existing
Methods. The training sequences for each EC number were
used to generate HMM proﬁles using the HMM-ModE
protocol as described in Methods. The average sensitivity
and speciﬁcity distributions of the n sets in the n-fold cross
validation exercise provide us with a conﬁdence measure
with which to use the proﬁles. If the original proﬁle HMM
selects false positives from within the negative training
sequences, the information from these is used to modify the
emission probabilities of the HMM so that it becomes more
speciﬁc.
The ModEnzA proﬁles were used to scan the complete
genomes of organisms to assess the performance of our
method. Following the example of [22, 24], we chose three
bacterial genomes (E. coli, B. aphidicola,a n dM. pneumo-
niae) which have been extensively annotated using both
manual and automatic methods as part of the high-quality
automated and manual annotation of microbial proteomes
project [40] and one eukaryotic genome (P. falciparum),
for which detailed descriptions of function are available
from the PlasmoDB resource [44]. The enzymatic function
annotations from these sources were used as benchmarks for
comparing the sensitivity and speciﬁcity of ModEnzA with
other enzyme identiﬁcation methods PRIAM, MetaSHARK,
and EFICAz (see Section 2).
Identiﬁcation of functional residues or residues that
are responsible for imparting functional speciﬁcity is a
critical step toward constructing function speciﬁc proﬁles.
Information theoretic measures such as positional entropy
[45] and mutual information [46] have earlier been used for
this purpose. EFICAz employs an evolutionary footprinting
approach which scores each position in an alignment of
a family of sequences by a combination of entropy based
conservation scores in (1) the “homofunctional” alignment,
that is, consisting of members of the same family and (2)
a “heterofunctional” alignment which consists of similar
sequences (which might have diﬀerent functions), mined
from a nonredundant database using the homofunctional
proﬁleHMM.Thealignmentpositionsarethenrankedusing
a Z-score of the conservation degree to identify functionally
discriminating residues (FDRs). HMM-ModE, the protocol
upon which ModEnzA is based, uses a similar concept of
negative training sequences,theseare sequencesbelongingto
other functional families which are scored positively by the
HMM for a particular family. We use a position-dependent
null model which contains conservation information from
these negative training sequences. We calculate the relative
entropy between the distributions of amino acids in the
alignments of the positive and negative training sequences
and select residues where this score is higher than the
relative entropy between the positive sequences and the
null set (i.e., the null probabilities as calculated from
the swissprot sequences). The probabilities of the amino
acids in the negative set are used to modify the emission
probabilities of these selected residues to generate a function
speciﬁc proﬁle HMM. This avoids the problem of loss of
information associated with using a Z-score cutoﬀ [35]. The
discrimination potential of a proﬁle is a function of the
unique nature of the family at the level of both its fold
and speciﬁcity determining positions. As a consequence, the
discriminating potential of a proﬁle HMM at a functional
level would be expected to be dependent on the frequency
of occurrence of the parent fold among proteins, that is,
an activity that arises in a commonly occurring fold will
be more likely to have false positives from the complete
training set than an activity that arises in a fold that is not
so wide-spread. As such, there is no discernible relationship
between the cluster size (no. of training sequences available
for a subgroup) and the discrimination potential of the
corresponding proﬁle (Supplementary Figure SF2 available
online at doi:10.1155/2011/743782).
EFICAzusesafamilyspeciﬁcSequenceIdentitythreshold
(SIT), which is set after making all pairwise sequence com-
parisons within the family, for predicting enzyme function
[25]. Both PRIAM and MetaShark have options for varying
the e-value threshold. An E-value cutoﬀ of 10−10 in PRIAM
results in a high sensitivity (92.61%) but a speciﬁcity of only
82.25%foridentifyingECnumbersfromE.coli.Ontheother
hand, using a stringent E-value cutoﬀ of 10−30 increases
speciﬁcity (90.42%)with adropinsensitivity (90.80%)(data
not shown). This is a drawback of using arbitrary thresholds
for discrimination. ModEnzA uses cross-validation to ensure
an optimal threshold for each separate proﬁle [32]t h e r e b y
eliminating the use of arbitrary thresholds.
The EFICAz webserverat http://cssb2.biology.gatech.edu
/cgi-bin/eﬁcaz browse.cgi provides 4 digit EC number pre-
dictions for a number of genomes. These predictions were
directly compared with ModEnzA. The sensitivity and speci-
ﬁcity were calculated with respect to the EC numbers that
were correctly assigned to a genome as well as the sequences
associated with an enzymatic activity which were identiﬁed
by the methods. The comparative performance of EFICAz
and ModEnzA for identifying EC numbers and enzymatic
s e q u e n c e sf r o mt h ef o u rg e n o m e si ss h o w ni nTable 1.T h e
sensitivity and speciﬁcity values of the ModEnzA proﬁles are
higher compared to EFICAz both in assigning EC numbers8 Advances in Bioinformatics
as well as identifying enzymatic sequences. As expected, the
sensitivity is improved by the inclusion of the Tier II and
Tier III proﬁles (the sensitivity in assigning EC-associated
sequences increasing up to 97% for B. aphidicola, e.g.) but
there is a slight drop in the speciﬁcity because the training
sequences were mined from the NR database and hence
may have errors of annotation. The Tier I ModEnzA proﬁles
by themselves show a higher speciﬁcity than EFICAz while
selecting enzymatic sequences for each genome tested. The
augmentation by Tier II and III proﬁles still maintains an
on par speciﬁcity while increasing the sensitivity to a value
greater than that of EFICAz for identifying bothEC numbers
and sequences. Given that the genome databases mentioned
above also have an automated annotation component to
them, it must be noted that choosing a diﬀerent set of anno-
tations as the benchmark (e.g KEGG) does not signiﬁcantly
alter the conclusions of the comparisons (supplementary
Table ST3 available online at doi:10.1155/2011/743782).
The PRIAM and MetaShark methods use the July 2006
version of the ENZYME database as the training set. To
ensure a fair comparison we rebuilt all the ModEnzA proﬁles
using the July 2006 ENZYME version. As demonstrated in
the next section, the KEGG database has more EC-sequence
associations for P. falciparum than PlasmoDB, and for this
reason we replaced PlasmoDB with KEGG as the bench-
mark for the comparison of ModEnzA with PRIAM and
MetaShark. Receiver-operator characteristic (ROC) curves
serve as an indicator for the discriminating potential of
a classiﬁer method. The ROC curves for the retrained
ModEnzA (ModEnzA-RT) proﬁles as well as PRIAM and
MetaShark are shown in Figure 2(a).S i n c eE F I C A zu s e s
4d i ﬀerent methods, each with its own set of parameters,
we could not include EFICAz in this analysis. The area
under the ROC curve for the ModEnzA proﬁles is better
than both PRIAM and MetaShark for all the four genomes.
MetaShark predictions on P. falciparum suﬀer from very
low speciﬁcity (Figure 2(a), bottom left panel) probably
because it is diﬃcult to map the proﬁle HMMs back onto
its DNA sequence which is atypically AT rich and contains
lots of repetitive sequences [47]. The ROC curves for
ModEnzA scans on the entire genomesof thefour organisms
(Figure 2(b)) show the high discrimination potential of the
ModEnzA proﬁles.
3.4. Enzyme Identiﬁcation from the P. falciparum Genome.
Eukaryotic species account for only about 16% of the most
represented species (31% of all sequences) in terms of
number of sequence entries in Swiss-Prot (http://ca.expasy.
org/sprot/relnotes/relstat.html). The P. falciparum genome is
also not included in the HAMAP project which deals exten-
sively with bacterial, archaeal, and plastid encoded proteins.
Hence, this could be considered as an ideal case to compare
the various enzyme identiﬁcation methods. We chose the
PlasmoDB enzyme annotations as a benchmark to decide on
thetruepositive,falsepositive,andfalsenegativepredictions.
The sensitivity and speciﬁcity calculated in terms of these
numbers for ModEnzA and EFICAz is shown in Table 1.T h e
relative scarcity of training sequences from the eukaryotic
domain is reﬂected in the low sensitivities of the methods.
Table 1: Genome-wide enzyme identiﬁcation for three bacterial
genomes (E. coli, B. aphidicola,a n dM. pneumoniae)a n do n e
eukaryotic genome (P. falciparum) by ModEnzA and EFICAz.
Methods EFICAz ModEnzA
(TierI)
ModEnzA
(Tier I+II)
Annotation
benchmark HAMAP
E. coli
Sequences 1012 859 (1051) 902 (1021) 930 (1082)
Sensitivity 84.88 89.13 91.89
Speciﬁcity 81.73 88.34 85.95
EC numbers 755 653 (728) 663 (697) 699 (775)
Sensitivity 86.49 87.81 92.58
Speciﬁcity 89.69 95.12 90.19
B. aphidicola
Sequences 273 257 (273) 264 (271) 265 (273)
Sensitivity 94.13 96.7 97.07
Speciﬁcity 94.13 97.41 97.07
EC numbers 245 226 (238) 225 (229) 225 (233)
Sensitivity 92.24 91.83 91.83
Speciﬁcity 94.95 98.25 96.56
M. pneumoniae
Sequences 147 119 (149) 126 (139) 126 (139)
Sensitivity 80.95 85.71 85.71
Speciﬁcity 79.86 90.64 90.64
EC numbers 127 101 (122) 115 (122) 115 (122)
Sensitivity 79.52 90.55 90.55
Speciﬁcity 82.78 94.26 94.26
Annotation
benchmark PlasmoDB
P. falciparum
Sequences 771 341 (480) 350 (415) 358 (431)
Sensitivity 44.22 45.39 46.43
Speciﬁcity 71.04 84.33 83.06
EC numbers 410 217 (247) 212 (234) 215 (242)
Sensitivity 52.92 51.7 52.43
Speciﬁcity 87.85 90.59 88.84
Numbers within parentheses indicate the total number of sequences or EC
numbers identiﬁed by each method.
Again the speciﬁcity of the ModEnzA proﬁles is higher than
EFICAz.
ModEnzA assigned 22 EC numbers which were not
annotated in PlasmoDB (False Positives). We checked for
the corresponding functions of these EC numbers in two
other databases, namely KEGG (because it is often used
as a reference knowledge base) [12]a n dP l a s m o C y c[ 4]
(which also contains a comprehensive annotation of the
P. falciparum genome). We found that 13 of the 22 false
positive EC numbers have been annotated as belonging to
P. falciparum by either of these databases (Table 2).
We were interested in the ability of Tier II and Tier III
proﬁles to annotate novel sequences, especially as they wereAdvances in Bioinformatics 9
Table 2: Conﬂicting annotationsforthe 22 EC numbers predicted as belonging to the P. falciparum genomeby ModEnzAbut notannotated
in PlasmoDB.
EC No. Sequence KEGG PlasmoCyc
1.1.5.3 PFC0275w FAD-dependent glycerol-3-phosphate
dehydrogenase, putative
FAD-dependent glycerol-3-phosphate
dehydrogenase, putative
1.17.7.1 PF10 0221 (E)-4-Hydroxy-3-methylbut-2-enyl-diphosphate
synthase Methylerythritol phosphate pathway
1.3.1.8 PF11 0370 — —
1.3.5.2 PFF0160c — Uridine-5 -phosphate biosynthesis
2.1.1.48 PF14 0156 — —
2.3.1.180 PFB0505c 3-Oxoacyl-(acyl carrier protein) synthase III,
putative Fatty acid biosynthesis initiation I
2.3.1.181 MAL8P1.37 Lipoyl(octanoyl) transferase —
2.4.1.141 MAL8P1.133 Beta-1,4-N-acetylglucosaminyltransferase Dolichyl-diphosphooligosaccharide
biosynthesis
2.7.12.1 PF14 0431 dual-speciﬁcity kinase —
2.7.1.90 PFI0755c 6-phosphofructokinase ATP-dependent phosphofructokinase,
putative
2.7.7.64 PFE0875c — —
2.8.1.8 MAL13P1.220 Lipoic acid synthetase —
3.1.13.4 MAL8P1.104,
PFE0980c ——
3.1.21.2 PF13 0176 — —
3.4.21.10
PFE0340c,
PF11 0149,
MAL8P1.16,
PF14 0110
——
3.5.1.88 PFI0380c — —
3.6.1.1
PF14 0541,
PFL1700c,
PFC0710w-a,
PFC0710w-b
Inorganic pyrophosphatase
Inorganic pyrophosphatase, putative, V-type
H(+)-translocating pyrophosphatase,
putative
3.6.1.7 PF11 0121 — —
3.6.3.44 PFE1150w — ABC transporter, putative
3.6.4.3 PF14 0548 — —
3.6.4.6 PFC0140c Vesicle-fusing ATPase —
3.6.5.5 PF10 0368 Dynamin GTPase —
“—”–Annotation not present in either PlasmoCyc or KEGG.
createdfrom sequencesimilarity andnotexpert-curated data
sets. It was also interesting to address the fact that in the
absenceofa proﬁle,ModEnzAcouldbeusedtopickarelated
function.TheTierIIModEnzAproﬁlesselected14sequences
and 7 EC numbers, respectively, from the P. falciparum
genome (Table 3) .T h ec y s t e i n ep r o t e a s ef a l c i p a i ns e q u e n c e s
(gene IDs PF11 0161, PF11 0162, and PF11 0165), for
instance, do not currently have an EC number associated
with them. So in absence of a corresponding EC proﬁle,
ModEnzAannotatesitwiththenearest cysteineendopetidase
bromelain (EC 3.4.22.32) but it is gratifying to note that
the annotation is correct upto the general level of the ﬁrst
three E.C. digits. Three of the 7 EC numbers predicted
by ModEnzA exactly match the corresponding PlasmoDB
assignments while 3 others have the same ﬁrst three digits.
Only one EC assignment (EC 3.4.23.2) has more than 1
digit mismatch with the EC annotated in PlasmoDB. Of
the 14 sequences annotated, the EC assignments for 8 share
the ﬁrst three digits with the corresponding annotations
in PlasmoDB (Table 3). The Tier II and Tier III proﬁles
can annotate sequences up to the ﬁrst three EC digits with
suﬃcient accuracy. However, as has been mentioned earlier,
these should be used with caution, because the training
sequencesused for these proﬁles may be prone to annotation
errors.
As the results show, there is a discrepancy between the
annotations/predictions of diﬀerent databases. The Mod-
EnzA protocol assumes importance because it is a rapid tool
that provides a high degree of conﬁdence in assigning EC
numbers to a genome. A typical hmmsearch with ModEnzA
Tier I proﬁles on the E. coli genome (4407 proteins) takes
∼7.8Hrs on a laptop having a 2.4GHz core2duo Intel10 Advances in Bioinformatics
Table 3: Three-digit annotations for the sequences selected from P. falciparum by Tier II and Tier III proﬁles.
Gene PlasmoDBproduct
description∗ PlasmoDBEC∗ ModEnzA
EC EC description#
PF07 0059 4-nitrophenylphosphatase,
putative
3.1.3.-(Phosphoricmonoester
hydrolases.); 3.1.3.41
(4-nitrophenylphosphatase)
T2-
3.1.3.41 4-nitrophenylphosphatase
PF08 0108 Pepsinogen, putative 3.4.23.1 T2-
3.4.23.2 Pepsin B
PF10 0329 Aspartyl protease, putative;
PlasmepsinVII None T2-
3.4.23.2 Pepsin B
PF11 0161 Falcipain-2 precursor,
putative 3.4.22.- T3-
3.4.22.32 Stem bromelain
PF11 0162 Falcipain-3 3.4.22.- T3-
3.4.22.32 Stem bromelain
PF11 0165 Falcipain 2 precursor 3.4.22.- T3-
3.4.22.32 Stem bromelain
PF11 0295 Farnesyl pyrophosphate
synthase, putative
2.5.1.10
Geranyltranstransferase;
2.5.1.1
Dimethylallyltranstransferase
T2-
2.5.1.67
Chrysanthemyl
diphosphate synthase
PF14 0075 Plasmepsin,putative 3.4.23.38 (Plasmepsin I) T2-
3.4.23.39 PlasmepsinII
PF14 0076 Plasmepsin 1 precursor 3.4.23.38 (Plasmepsin I) T2-
3.4.23.39 PlasmepsinII
PF14 0077 Plasmepsin 2 3.4.23.39 (Plasmepsin II) T2-
3.4.23.39 PlasmepsinII
PF14 0078 HAP protein; Plasmepsin
III
3.4.23.-Aspartic
endopeptidases
T2-
3.4.23.39 PlasmepsinII
PF14 0281 Aspartyl protease, putative None T2-
3.4.23.2 Pepsin B
PF14 0334
NAD(P)H-dependent
glutamate synthase,
putative
1.4.7.1 Glutamate synthase
(ferredoxin);1.4.1.14
-Glutamate synthase (NADH)
T2-
1.4.1.14 Glutamate synthase
PF14 0553 Cysteine proteinase
falcipain-1 None T3-
3.4.22.32 Stem bromelain
PF14 0625 Hypothetical protein 3.4.2.3; Transferred entry:
3.4.17.4
T2-
3.4.23.2 Pepsin B
PFC0495w Aspartyl protease, putative 3.4.23.- Aspartic
endopeptidases
T2-
3.4.23.2 Pepsin B
PFF0530w Transketolase, putative 2.2.1.1 Transketolase T2-2.2.1.3 Formaldehyde
transketolase
PFI1125c
3-oxoacyl-(acyl-carrier
protein) reductase,
putative
1.1.1.100 (3-oxoacyl-[acyl-
carrier-protein] reductase);
2.3.1.85 (Fatty-acid synthase)
T2-
1.1.1.140
Sorbitol-6-phosphate
2-dehydrogenase
∗Gene product descriptions and EC annotations obtained from PlasmoDB. #IUBMB EC description.
processor and 3Gb RAM. The same search on a workstation
with a 2.50GHz Intel xeon quadcore processor with 8GB
RAM takes ∼2.2Hrs. Since the hmmsearch and hmmscan
program is inherently capable of multithreading, ModEnzA
canbeexpectedtobeevenfasteronmachineswithmor epr o-
cessors. For example, we were able to annotate the enzymes
in a metagenomic sample with 203240 translated protein
fragments with ModEnzA in just around 1.3hrs by splitting
the target sequences into 10 parts and using 10 nodes (each
withadualcoreprocessor)torunthehmmscanprogramona
high-performance computing cluster (unpublished results).
The n-fold cross validation routine built into ModEnzA on
the training sequences ensures an optimal threshold which
can separate the true positives from the False positives
for any given EC number. The modiﬁcation of emission
probabilities of the True positive proﬁles by using infor-
mation from the false positive alignment further increases
the speciﬁcity. We have decided to make this data available
for use by the scientiﬁc community using HMMER2,
even though HMMER3 has since been released [21].Advances in Bioinformatics 11
HMMER3 has only local-local alignments, and our method
is based on predicting the fold (domain) and hence is
implicitly based on global or “Glocal” (align a complete
model to a subsequence of the target) alignments. ModEnzA
is based on scripts that modify the emission probabilities in
the model, and it is unsure if the formats for HMMER3 are
stable enough to extract probabilities from the model. The
model has changed between the two versions, and it hasbeen
advised that proﬁles builton oneshould not be usedwith the
other, as parameters are diﬀerently optimised. When more
alignment modes are available and the format is more stable,
newer versions of ModEnzA would migrate to HMMER3 to
take advantage of the increased sensitivities and speed.
4.Conclusion
We present a method for enzyme annotation by enriching
existing curated databases and using proﬁle hidden Markov
models optimised for speciﬁcity using negative training
sequences. The protocol shows improved sensitivity and
speciﬁcity compared to other existing methods for enzyme
identiﬁcation and can be used to accurately map the meta-
bolome of an organism.
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